GGrantIndex
Sort

53,477 grants matching addiction

Glial-mediated synaptic remodeling in drug addiction

$526,620
Yan Dong · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · DA

Laboratory Resource

$526,604
Neal L Benowitz · University Of California, San Francisco · P30 · FY2013 · DA

RNA methylation in synaptic plasticity and drug-seeking

$526,596
Xiaoxi Zhuang · University Of Chicago · R01 · FY2021 · DA

Project 1: Translational Studies on Temperature and Solvent Effects on Electronic Cigarette-Derived Oxidants

$526,588
Thomas E Spratt · Pennsylvania State Univ Hershey Med Ctr · U54 · FY2023 · DA

Selective Monoamine Release as a Treatment for Cocaine Use Disorders

$526,586
William Walton Stoops · University Of Kentucky · R01 · FY2015 · DA

Vagus nerve stimulation increases basal dopamine levels in the brain to decrease methamphetamine-mediated responses

$526,583
Habibeh Khoshbouei · University Of Florida · R01 · FY2024 · DA

Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

$526,563
William Koppes · Painqx, Inc. · R44 · FY2020 · DA

SRI INTERNATIONAL:1110101 [19-010371]

$526,512
Maggie Baxter · Sri International · N01 · FY2023 · DA

Postdoctoral training in tobacco control

$526,498
Pamela May Ling · University Of California, San Francisco · T32 · FY2019 · CA

Personalized relapse prediction in Alcohol Use Disorder

$526,411
Anna Zilverstand · University Of Minnesota · R01 · FY2023 · AA

HIGH RISK TEEN TOBACCO USE PREVENTION THROUGH ADVOCACY

$526,410
Stanford University · R01 · FY2001 · DA

Pharmacogenetics of Oxycodone, Personalized Care and Persistent Surgical Pain

$526,410
Senthilkumar Sadhasivam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · HD

Multilevel and Longitudinal Study Sample Size Tools for Behavioral Scientists

$526,303
Keith E Muller · University Of Florida · R01 · FY2013 · DE

Role of prefrontostriatal circuits in effort-based, cost-benefit decision making

$526,198
Scott Allen Wilke · University Of California Los Angeles · R01 · FY2025 · MH

Depot Pharmacotherapies for Opioid-Dependent Offenders: Outcomes and Costs

$526,172
David J Farabee · University Of California Los Angeles · U01 · FY2013 · DA

Proof-of-Concept Human Laboratory Testing of Novel Drug Candidates Identified by INIA-NeuroImmune

$526,145
Barbara J Mason · Scripps Research Institute, The · U01 · FY2017 · AA

Citrulline-urea cycle in KSHV cellular transformation

$526,066
Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

Citrulline-urea cycle in KSHV cellular transformation

$526,066
Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA

Prolonged Smoking Cessation Using Prescription Step Care

$526,064
Robert C Klesges · University Of Tennessee Health Sci Ctr · R01 · FY2007 · CA

NK-1 Receptor Antagonism: A Role in Opioid Use Disorders

$526,063
Sharon L. Walsh · University Of Kentucky · R01 · FY2018 · DA

RNA methylation in synaptic plasticity and drug-seeking

$526,060
Xiaoxi Zhuang · University Of Chicago · R01 · FY2020 · DA

Imaging Nociceptin Receptors in Alcoholism

$526,023
Rajesh Narendran · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AA

HIV Risk Reduction for Drug Dependent Black Men

$525,980
University Of Michigan At Ann Arbor · R01 · FY2003 · DA

Mechanisms of Extinction Memory Enhancement for Cocaine Addiction Treatment

$525,941
Kathleen M. Kantak · Boston University (Charles River Campus) · R01 · FY2018 · DA

Examining the Impact of Stress on the Emotionally Reinforcing Properties of Alcohol in Heavy Social Drinkers: A Multimodal Investigation Integrating Laboratory and Ambulatory Methods

$525,929
Catharine Fairbairn · University Of Illinois At Urbana-Champaign · R01 · FY2024 · AA